Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC). The company employs an antibody-based technique based on the genetic profile of each patient’s tumor that destroys tumor cells while leaving other normal cells alone in the body. The company offers patients a low-cost, effective medication while minimizing the danger of unwanted effects.
Something missing or incorrect on this page? Help us enrich this information
